Surface antigens

Pneumocystis Pneumonia: Third Edition, Revised and Expanded

Volumn , Issue , 2004, Pages 95-126

  Stringer, James R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057248241     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (146)

1. Pesanti EL, Shanley JD. Glycoproteins of Pneumocystis carinii: characterization by electrophoresis and microscopy. J Infect Dis 1988; 158:1353-1359.
2. Radding JA, Armstrong MY, Ullu E, Richards FF. Identification and isolation of a major cell surface glycoprotein of Pneumocystis carinii. Infect Immun 1989; 57: 2149-2157.
3. Linke MJ, Walzer PD. Analysis of a surface antigen of Pneumocystis carinii. J Protozool 1989; 36:60S-61S.
4. Cushion MT, DeStefano JA, Walzer PD. Pneumocystis carinii: surface reactive carbohydrates detected by lectin probes. Exp Parasitol 1988; 67:137-147.
5. Graves DC, McNabb SJ, Ivey MH, Worley MA. Development and characterization of monoclonal antibodies to Pneumocystis carinii. Infect Immun 1986; 51:125-133.
6. Linke MJ, Cushion MT, Walzer PD. Properties of the major antigens of rat and human Pneumocystis carinii. Infect Immun 1989; 57:1547-1555.
7. Nakamura Y, Tanabe K, Egawa K. Structure of major surface determinants and DNA diagnosis of Pneumocystis carinii. J Protozool 1989; 36:58S-60S.
8. Tanabe K, Takasaki S, Watanabe J, Kobata A, Egawa K, Nakamura Y. Glycoproteins composed of major surface immunodeterminants of Pneumocystis carinii. Infect Immun 1989; 57:1363-1368.
9. Kovacs JA, Halpern JL, Lundgren B, Swan JC, Parrillo JE, Masur H. Monoclonal antibodies to Pneumocystis carinii: identification of specific antigens and characterization of antigenic differences between rat and human isolates. J Infect Dis 1989; 159:60-70.
10. Linke MJ, Walzer PD. Identification and purification of a soluble species of gp 120 released by zymolyase treatment of Pneumocystis carinii. J Protozool 1991; 38: 176S-178S.
11. Linke MJ, Smulian AG, Yoshihara P, Walzer PD. Production and characterization of monoclonal antibodies specific for the major surface glycoprotein of Pneumocystis carinii. J Eukaryot Microbiol 1994; 41:99S-100S.
12. Gigliotti F, Stokes DC, Cheatham AB, Davis DS, Hughes WT. Development of murine monoclonal antibodies to Pneumocystis carinii. J Infect Dis 1986; 154: 315-322.
13. Gigliotti F, Ballou LR, Hughes WT, Mosley BD. Purification and initial characterization of a ferret Pneumocystis carinii surface antigen. J Infect Dis 1988; 158:848-854.
14. Gigliotti F. Host species-specific antigenic variation of a mannosylated surface glycoprotein of Pneumocystis carinii. J Infect Dis 1992; 165:329-336.
15. Lundgren B, Lipschik GY, Kovacs JA. Purification and characterization of a major human Pneumocystis carinii surface antigen. J Clin Invest 1991; 87:163-170.
16. Lundgren B, Koch C, Mathiesen L, Nielsen JO, Hansen JE. Glycosylation of the major human Pneumocystis carinii surface antigen. APMIS 1993; 101:194-200.
17. Peglow SL, Smulian AG, Linke MJ, Pogue CL, Nurre S, Crisler J, et al. Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis 1990; 161:296-306.
18. Graves DC, McNabb SJ, Worley MA, Downs TD, Ivey MH. Analyses of rat Pneumocystis carinii antigens recognized by human and rat antibodies by using Western immunoblotting. Infect Immun 1986; 54:96-103.
19. Kovacs JA, Halpern JL, Swan JC, Moss J, Parrillo JE, Masur H. Identification of antigens and antibodies specific for Pneumocystis carinii. J Immunol 1988; 140: 2023-2031.
20. Tamburrini E, Ortona E, Visconti E, Mencarini P, Margutti P, Zolfo M, et al. Pneumocystis carinii infection in young non-immunosuppressed rabbits. Kinetics of infection and of the primary specific immune response. Med Microbiol Immunol (Berl) 1999; 188(1):1-7.
21. Gigliotti F, Garvy BA, Haidaris CG, Harmsen AG. Recognition of Pneumocystis carinii antigens by local antibody- secreting cells following resolution of P. carinii pneumonia in mice. J Infect Dis 1998; 178:235-242.
22. Cushion MT, Walzer PD, Smulian AG, Linke MJ, Ruffolo JJ, Kaneshiro ES, et al. Terminology for the life cycle of Pneumocystis carinii [letter; comment]. Infect Immun 1997; 65:4365; discussion 436.
23. Ruffolo JJ. Pneumocystis carinii cell structure. Walzer PD, Ed. Pneumocystis carinii Pneumonia. New York: Marcel Dekker, 1994:25-43.
24. Chatterton JM, Joss AW, Pennington TH. Ho-Yen DO. Differences exist in the immunoblotting profiles of cyst and trophozoite antigens of Pneumocystis carinii. J Med Microbiol 1995; 42:120-126.
25. Bauer NL, Paulsrud JR, Bartlett MS, Smith JW. Pneumocystis carinii organisms obtained from rats, ferrets, and mice are antigenically different. Infect Immun 1993; 61:1315-1319.
26. Stringer JR, Cushion MT, Wakefield AE. New nomenclature for the genus Pneumocystis. Proceedings of the Seventh International Workshops on Opportunistic Protists. J Eukaryot Microbiol 2001(Suppl):184s-189s.
27. Andrews RP, Theus SA, Cushion MT, Walzer PD. Comparison of the antigenic recognition of the major surface glycoprotein of Pneumocystis carinii isolated from different rat strains. J Eukaryot Microbiol 1994; 41:72S.
28. Vasquez J, Smulian AG, Linke MJ, Cushion MT. Antigenic differences associated with genetically distinct Pneumocystis carinii from rats. Infect Immun 1996; 64: 290-297.
29. Smulian AG, Stringer JR, Linke MJ, Walzer PD. Isolation and characterization of a recombinant antigen of Pneumocystis carinii. Infect Immun 1992; 60:907-915.
30. Smulian AG, Theus SA, Denko N, Walzer PD, Stringer JR. A 55 kDa antigen of Pneumocystis carinii: analysis of the cellular immune response and characterization of the gene. Mol Microbiol 1993; 7:745-753.
31. Broomall KR, Morris RE, Walzer PD, Smulian AG. Zymolyase treatment exposes p55 antigen of Pneumocystis carinii. J Eukaryot Microbiol 1998; 45:284-289.
32. Pottratz ST, Paulsrud J, Smith JS. Martin WJII. Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. J Clin Invest 1991; 88:403-407.
33. Nakamura Y, Kitada K, Wada M, Saito M. Epitope study and cDNA screening of major surface glycoprotein of Pneumocystis carinii. J Protozool 1991; 38:3S-4S.
34. Paulsrud JR, Queener SF, Bartlett MS, Smith JW. Isolation and characterization of rat lung Pneumocystis carinii gp 120. J Protozool 1991; 38:10S—11S.
35. Radding JA, Armstrong MY, Bogucki MS, Richards FF. Surface labeling of Pneumocystis carinii from in vitro culture. J Protozool 1989; 36:61S-62S.
36. Gigliotti F, McCool T. Glycoprotein A is the immunodominant antigen of Pneumocystis carinii in mice following immunization. Parasitol Res 1996; 82:90-91.
37. Haidaris PJ, Wright TW, Gigliotti F, Haidaris CG. Expression and characterization of a cDNA clone encoding an immunodominant surface glycoprotein of Pneumocystis carinii. J Infect Dis 1992; 166:1113-1123.
38. Kovacs JA, Powell F, Edman JC, Lundgren B, Martinez A, Drew B, et al. Multiple genes encode the major surface glycoprotein of Pneumocystis carinii. J Biol Chem 1993; 268:6034-6040.
39. Wada M, Kitada K, Saito M, Egawa K, Nakamura Y. cDNA sequence diversity and genomic clusters of major surface glycoprotein genes of Pneumocystis carinii. J Infect Dis 1993; 168:979-985.
40. Linke MJ, Smulian AG, Stringer JR, Walzer PD. Characterization of multiple unique cDNAs encoding the major surface glycoprotein of rat-derived Pneumocystis carinii. Parasitol Res 1994; 80:478-486.
41. Linke MJ, Sunkin SM, Andrews RP, Stringer JR, Walzer PD. Expression, structure, and location of epitopes of the major surface glycoprotein of Pneumocystis carinii f. sp carinii. Clin Diagn Lab Immunol 1998; 5(1):50-57.
42. Schaffzin JK, Stringer JR. Direct correlation of genomic localization and surface expression of the major surface glycoprotein of Pneumocystis carinii [In Process Citation]. J Eukaryot Microbiol 1999; 46:127S.
43. Wada M, Nakamura Y. MSG gene cluster encoding major cell surface glycoproteins of rat Pneumocystis carinii. DNA Res 1994; 1:163-168.
44. Lugli EB, Allen AG, Wakefield AE. A Pneumocystis carinii multi-gene family with homology to subtilisin-like serine proteases. Microbiology 1997; 143:2223-2236.
45. Russian DA, Andrawis-Sorial V, Goheen MP, Edman JC, Vogel P, Turner RE, et al. Characterization of a multicopy family of genes encoding a surface-expressed serine endoprotease in rat Pneumocystis carinii. Proc Assoc Am Physicians 1999; 111:347-356.
46. Wada M, Nakamura Y. Immunological characterization of surface subtilisin-like protease (SSP) of Pneumocystis carinii. J Eukaryot Microbiol 1999; 46:151S-152S.
47. Julius D, Brake A, Blair L, Kunisawa R, Thorner J. Isolation of the putative structural gene for the lysine-arginine-cleaving endopeptidase required for processing of yeast prepro-alpha-factor. Cell 1984; 37:1075-1089.
48. Lee LH, Gigliotti F, Wright TW, Simpson-Haidaris PJ, Weinberg GA, Haidaris CG. Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene 2000; 242(1-2):141-150.
49. Schaffzin JK, Sunkin SM, Stringer JR. A new family of Pneumocystis carinii genes related to those encoding the major surface glycoprotein. Curr Genet 1999; 35: 134-143.
50. Wada M, Nakamura Y. Type-II major-surface-glycoprotein family of Pneumocystis carinii under the control of novel expression elements. DNA Res 1999; 6:211-217.
51. Huang SN, Angus CW, Turner RE, Sorial V, Kovacs JA. Identification and characterization of novel variant major surface glycoprotein gene families in rat Pneumocystis carinii. J Infect Dis 1999; 179:192-200.
52. Stringer SL, Hong ST, Giuntoli D, Stringer JR. Repeated DNA in Pneumocystis carinii. J Clin Microbiol 1991; 29:1194-1201.
53. Sunkin SM, Stringer SL, Stringer JR. A tandem repeat of rat-derived Pneumocystis carinii genes encoding the major surface glycoprotein. J Eukaryot Microbiol 1994; 41:292-300.
54. Underwood AP, Louis EJ, Borts RH, Stringer JR, Wakefield AE. Pneumocystis carinii telomere repeats are composed of TTAGGG and the subtelomeric sequence contains a gene encoding the major surface glycoprotein. Mol Microbiol 1996; 19: 273-281.
55. Lugli EB, Bampton ET, Ferguson DJ, Wakefield AE. Cell surface protease PRT1 identified in the fungal pathogen Pneumocystis carinii [In Process Citation]. Mol Microbiol 1999; 31:1723-1733.
56. Wada M, Sunkin SM, Stringer JR, Nakamura Y. Antigenic variation by positional control of major surface glycoprotein gene expression in Pneumocystis carinii. J Infect Dis 1995; 171:1563-1568.
57. Kitada K, Wada M, Nakamura Y. Multi-gene family of major surface glycoproteins of Pneumocystis carinii: full-size cDNA cloning and expression. DNA Res 1994; 1:57-66.
58. Cushion MT, Kaselis M, Stringer SL, Stringer JR. Genetic stability and diversity of Pneumocystis carinii infecting rat colonies. Infect Immun 1993; 61:4801-4813.
59. Arnold J, Cushion MT. Constructing a physical map of the Pneumocystis genome. J Eukaryot Microbiol 1997; 44:8S.
60. Lundgren B, Cotton R, Lundgren JD, Edman JC, Kovacs JA. Identification of Pneumocystis carinii chromosomes and mapping of five genes. Infect Immun 1990; 58: 1705-1710.
61. Yoganathan T, Lin H, Buck GA. An electrophoretic karyotype and assignment of ribosomal genes to resolved chromosomes of Pneumocystis carinii. Mol Microbiol 1989; 3:1473-1480.
62. Sunkin SM, Stringer JR. Translocation of surface antigen genes to a unique telomeric expression site in Pneumocystis carinii. Mol Microbiol 1996; 19:283-295.
63. Edman JC, Hatton TW, Nam M, Turner R, Mei Q, Angus CW, et al. A single expression site with a conserved leader sequences regulates variation of expression of the Pneumocystis carinii family of major surface glycoprotein genes. DNA Cell Biol 1996; 15:989-999.
64. Wada M, Nakamura Y. Unique telomeric expression site of major-surface-glycoprotein genes of Pneumocystis carinii. DNA Res 1996; 3:55-64.
65. Sunkin SM, Stringer JR. Residence at the expression site is necessary and sufficient for the transcription of surface antigen genes of Pneumocystis carinii. Mol Microbiol 1997; 25(1):147-160.
66. Keely SP, Cushion MT, Stringer JR. Determination of the maximum frequency of genetic rearrangements associated with Pneumocystis carinii surface antigen variation [In Process Citation]. J Eukaryot Microbiol 1999; 46:128S.
67. Cushion MT, Linke MJ, Collins M, Keely SP, Stringer JR. The minimum number of Pneumocystis carinii f. sp. carinii organisms required to establish infections is very low [In Process Citation]. J Eukaryot Microbiol 1999; 46:111S.
68. Keely SP, Cushion MT, Stringer JR. Stability of four genetic loci in Pneumocystis carinii sp. f. carinii. J Eukaryot Microbiol 1996; 43:49S.
69. Walder JA, Eder PS, Engman DM, Brentano ST, Walder RY, Knutzon DS, et al. The 35-nucleotide spliced leader sequence is common to all trypanosome messenger RNAs. Science 1986; 233(4763):569-571.
70. Sunkin SM, Linke MJ, McCormack FX, Walzer PD, Stringer JR. Identification of a putative precursor to the major surface glycoprotein of Pneumocystis carinii. Infect Immun 1998; 66:741-746.
71. Angus CW, Tu A, Vogel P, Qin M, Kovacs JA. Expression of variants of the major surface glycoprotein of Pneumocystis carinii. J Exp Med 1996; 183:1229-1234.
72. Stringer SL. Pneumocystis genetic and antigenic variation. In: Jacobs LN, Ed. Fungal Disease: Biology, Immunology, and Diagnosis, Marcel Dekker. 1997:423-449.
73. Barry JD. The relative significance of mechanisms of antigen variation in African trypanosomes. Parasitol Today 1997; 13:212-218.
74. Borst P, Bitter W, Blundell PA, Chaves I, Cross M, Gerrits H, et al. Control of VSG gene expression sites in Trypanosoma brucei. Mol Biochem Parasitol 1998; 91: 67-76.
75. Barbour AG, Burman N, Carter CJ, Kitten T, Bergstrom S. Variable antigen genes of the relapsing fever agent Borrelia hermsii are activated by promoter addition. Mol Microbiol 1991; 5:489-493.
76. Restrepo BI, Barbour AG. Antigen diversity in the bacterium B. hermsii through ‘somatic’ mutations in rearranged vmp genes. Cell 1994; 78:867-876.
77. Zhang JR, Hardham JM, Barbour AG, Norris SJ. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 1997; 89:275-285.
78. Icenhour CR, Rebholz SL, Collins MS, Cushion MT. Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs. J Clin Microbiol 2001; 39(10):3437-3441.
79. Weisbroth SH, Geistfeld J, Weisbroth SP, Williams B, Feldman SH, Linke MJ, et al. Latent Pneumocystis carinii infection in commercial rat colonies: comparison of inductive immunosuppressants plus histopathology, PCR, and serology as detection methods [In Process Citation]. J Clin Microbiol 1999; 37:1441-1446.
80. Cushion MT. Transmission and epidemiology. In: Walzer PD, Ed. Pneumocystis carinii Pneumonia. New York: Marcel Dekker, 1994:123-140.
81. Denis CM, Mazars E, Guyot K, Odberg-Ferragut C, Viscogliosi E, Dei-Cas E, et al. Genetic divergence at the SODA locus of six different formae speciales of Pneumocystis carinii. Med Mycol 2000; 38(4):289-300.
82. Nielsen MH, Settnes OP, Aliouat EM, Cailliez JC, Dei-Cas E. Different ultrastructural morphology of Pneumocystis carinii derived from mice, rats, and rabbits. APMIS 1998; 106:771-779.
83. Mazars E, Guyot K, Fourmaintraux S, Renaud F, Petavy F, Camus D, et al. Detection of Pneumocystis in European wild animals. J Eukaryot Microbiol 1997; 44:39S.
84. Demanche C, Berthelemy M, Petit T, Polack B, Wakefield AE, Dei-Cas E, et al. Phylogeny of Pneumocystis carinii from 18 primate species confirms host specificity and suggests coevolution. J Clin Microbiol 2001; 39(6):2126-2133.
85. Palmer RJ, Settnes OP, Lodal J, Wakefield AE. Population structure of rat-derived Pneumocystis carinii in Danish wild rats. Appl Environ Microbiol 2000; 66(11): 4954-4961.
86. Laakkonen J, Henttonen H, Niemimaa J, Soveri T. Seasonal dynamics of Pneumocystis carinii in the field vole, Microtus agrestis, and in the common shrew, Sorex araneus, in Finland. Parasitology 1999; 118:1-5.
87. Laakkonen J. Pneumocystis carinii in wildlife. Int J Parasitol 1998; 28:241-252.
88. Bishop R, Gurnell J, Laakkonen J, Whitwell K, Peters S. Detection of Pneumocystis DNA in the lungs of several species of wild mammal. J Eukaryot Microbiol 1997; 44:57S.
89. Wakefield AE, Stringer JR, Tamburrini E, Dei-Cas E. Genetics, metabolism and host specificity of Pneumocystis carinii. Med Mycol 1998; 36(suppl 1):183-193.
90. Wright TW, Simpson Haidaris PJ, Gigliotti F, Harmsen AG, Haidaris CG. Conserved sequence homology of cysteine-rich regions in genes encoding glycoprotein A in Pneumocystis carinii derived from different host species. Infect Immun 1994; 62: 1513-1519.
91. Haidaris CG, Wright TW, Gigliotti F, Haidaris PJ. Molecular cloning and characterization of ferret Pneumocystis carinii gp 120. J Protozool 1991; 38:5S-6S.
92. Haidaris CG, Medzihradsky OF, Gigliotti F, Simpson-Haidaris PJ. Molecular characterization of mouse Pneumocystis carinii surface glycoprotein A. DNA Res 1998; 5:77-85.
93. Christensen CB, Settnes OP, Bille-Hansen V, Jorsal SE, Henriksen SA, Lundgren B. Pneumocystis carinii from pigs and humans are antigenically distinct. J Med Vet Mycol 1996; 34:431-433.
94. Wright TW, Gigliotti F, Haidaris CG, Simpson-Haidaris PJ. Cloning and characterization of a conserved region of human and rhesus macaque Pneumocystis carinii gpA. Gene 1995; 167:185-189.
95. Mei Q, Turner RE, Sorial V, Klivington D, Angus CW, Kovacs JA. Characterization of major surface glycoprotein genes of human Pneumocystis carinii and high-level expression of a conserved region. Infect Immun 1998; 66:4268-4273.
96. Garbe TR, Stringer JR. Molecular characterization of clustered variants of genes encoding major surface antigens of human Pneumocystis carinii. Infect Immun 1994; 62:3092-3101.
97. Stringer SL, Garbe T, Sunkin SM, Stringer JR. Genes encoding antigenic surface glycoproteins in Pneumocystis from humans. J Eukaryot Microbiol 1993; 40: 821-826.
98. Schaffzin JK, Stringer JR. the major surface glycoprotein expression sites of two special forms of rat Pneumocystis carinii differ in structure. J Infect Dis 2000; 181: 1729-1739.
99. Wright TW, Bissoondial TY, Haidaris CG, Gigliotti F, Haidaris PJ. Isoform diversity and tandem duplication of the glycoprotein A gene in ferret Pneumocystis carinii. DNA Res 1995; 2:77-88.
100. Kutty G, Ma L, Kovacs JA. Characterization of the expression site of the major surface glycoprotein of human-derived Pneumocystis carinii. Mol Microbiol 2001; 42(1):183-193.
101. Theus SA, Sawhney N, Smulian AG, Walzer PD. Proliferative and cytokine responses of human T lymphocytes isolated from human immunodeficiency virus-infected patients to the major surface glycoprotein of Pneumocystis carinii. J Infect Dis 1998; 177(1):238-241.
102. Theus SA, Andrews RP, Linke MJ, Walzer PD. Characterization of rat CD4 T cell clones specific for the major surface glycoprotein of Pneumocystis carinii. J Eukar-yot Microbiol 1997; 44:96-100.
103. Fisher DJ, Gigliotti F, Zauderer M, Harmsen AG. Specific T-cell response to a Pneumocystis carinii surface glycoprotein (gp 120) after immunization and natural infection. Infect Immun 1991; 59:3372-3376.
104. Lundgren B, Lundgren JD, Nielsen T, Mathiesen L, Nielsen JO, Kovacs JA. Antibody responses to a major Pneumocystis carinii antigen in human immunodeficiency virus-infected patients with and without P. carinii pneumonia. J Infect Dis 1992; 165:1151-1155.
105. Lundgren B, Kovacs JA, Mathiesen L, Nielsen JO, Lundgren JD. IgM response to a human Pneumocystis carinii surface antigen in HIV-infected patients with pulmonary symptoms. Scand J Infect Dis 1993; 25:515-520.
106. Lundgren B, Lebech M, Lind K, Nielsen JO, Lundgren JD. Antibody response to a major human Pneumocystis carinii surface antigen in patients without evidence of immunosuppression and in patients with suspected atypical pneumonia. Eur J Clin Microbiol Infect Dis 1993; 12:105-109.
107. Gigliotti F, Wiley JA, Harmsen AG. Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia. Infect Immun 1998; 66:3179-3182.
108. Theus SA, Walzer PD. Adoptive transfer of specific lymphocyte populations sensitized to the major surface glycoprotein of Pneumocystis carinii decreases organism burden while increasing survival rate in the rat. J Eukaryot Microbiol 1997; 44: 23S-24S.
109. Theus SA, Smulian AG, Steele P, Linke MJ, Walzer PD. Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response. Vaccine 1998; 16:1149-1157.
110. Theus SA, Andrews RP, Steele P, Walzer PD. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat. J Clin Invest 1995; 95:2587-2593.
111. Gigliotti F, Harmsen AG. Pneumocystis carinii host origin defines the antibody specificity and protective response induced by immunization. J Infect Dis 1997; 176(5):1322-1326.
112. Garvy BA, Wiley JA, Gigliotti F, Harmsen AG. Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses. Infect Immun 1997; 65(12):5052-5056.
113. Gigliotti F, Hughes WT. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J Clin Invest 1988; 81:1666-1668.
114. Gigliotti F, Garvy BA, Hatmsen AG. Antibody-mediated shift in the profile of glycoprotein A phenotypes observed in a mouse model of Pneumocystis carinii pneumonia. Infect Immun 1996; 64:1892-1899.
115. Gigliotti F, Haidaris CG, Wright TW, Harmsen AG. Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia. Infect Immun 2002; 70(3):1069-1074.
116. Roths JB, Sidman CL. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4 + but not CD8 + T cells into severe combined immunodeficiency mice. J Clin Invest 1992; 90:673-678.
117. Roths JB, Sidman CL. Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice. Infect Immun 1993; 61:1641-1649.
118. Smulian AG, Linke MJ, Cushion MT, Baughman RP, Frame PT, Dohn MN, et al. Analysis of Pneumocystis carinii organism burden, viability and antigens in bronchoalveolar lavage fluid in AIDS patients with pneumocystosis: correlation with disease severity. AIDS 1994; 8:1555-1562.
119. Smulian AG, Sullivan DW, Theus SA. Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization. Microbes Infect 2000; 2(2):127-136.
120. Hughes WT, Kim HK, Price RA, Miller C. Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis. Curr Ther Res Clin Exp 1973; 15(8):581-587.
121. Lasbury ME, Angus CW, Klivington D, Durant PJ, Bartlett MS, Smith JW, et al. Recombinant major surface glycoprotein of Pneumocystis carinii elicits a specific immune response but is not protective in immunosuppressed rats. J Eukaryot Microbiol 1999; 46(5):136S-137S.
122. Pottratz ST. Pneumocystis carinii interactions with respiratory epithelium. Semin Respir Infect 1998; 13:323-329.
123. Walzer PD. Immunological features of Pneumocystis carinii infection in humans. Clin Diagn Lab Immunol 1999; 6:149-155.
124. Limper AH. Alveolar macrophage and glycoprotein responses to Pneumocystis carinii. Semin Respir Infect 1998; 13:339-347.
125. Vassallo R, Kottom TJ, Standing JE, Limper AH. Vitronectin and fibronectin function as glucan binding proteins augmenting macrophage responses to Pneumocystis carinii. Am J Respir Cell Mol Biol 2001; 25(2):203-211.
126. Pottratz ST, Paulsrud JR, Smith JS, WJ II. Evidence for Pneumocystis carinii binding to a cell-free substrate: role of the adhesive protein fibronectin. J Lab Clin Med 1994; 123:273-281.
127. Aliouat EM, Cas E, Ouaissi A, Palluault F, Soulez B, Camus D. In vitro attachment of Pneumocystis carinii from mouse and rat origin. Biol Cell 1993; 77:209-217.
128. Atochina EN, Beck JM, Scanlon ST, Preston AM, Beers MF. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D. J Lab Clin Med 2001; 137(6):429-439.
129. O’Riordan DM, Standing JE, Kwon KY, Chang D, Crouch EC, Limper AH. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest 1995; 95:2699-2710.
130. Vuk-Pavlovic Z, Standing JE, Crouch EC, Limper AH. Carbohydrate recognition domain of surfactant protein D mediates interactions with Pneumocystis carinii glycoprotein A. Am J Respir Cell Mol Biol 2001; 24(4):475-484.
131. Zimmerman PE, Voelker DR, McCormack FX, Paulsrud JR, WJ II. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest 1992; 89: 143-149.
132. McCormack FX, Festa AL, Andrews RP, Linke M, Walzer PD. The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii. Biochemistry 1997; 36:8092-8099.
133. Linke MJ, Harris CE, Korfhagen TR, McCormack FX, Ashbaugh AD, Steele P, et al. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection. J Infect Dis 2001; 183(6):943-952.
134. Masur H, Jones TC. The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med 1978; 147(1):157-170.
135. O’Riordan DM, Standing JE, Limper AH. Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect Immun 1995; 63:779-784.
136. Ezekowitz RA, Williams DJ, Koziel H, Armstrong MY, Warner A, Richards FF, et al. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 1991; 351:155-158.
137. Beck JM, Harmsen AG. Lymphocytes in host defense against Pneumocystis carinii. Semin Respir Infect 1998; 13:330-338.
138. Hanano R, Reifenberg K, Kaufmann SH. Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii. Infect Immun 1998; 66(1): 305-314.
139. Fraser IP, Takahashi K, Koziel H, Fardin B, Harmsen A, Ezekowitz RA. Pneumocystis carinii enhances soluble mannose receptor production by macrophages. Microbes Infect 2000; 2(11):1305-1310.
140. Castro M, Morgenthaler TI, Hoffman OA, Standing JE, Rohrbach MS, Limper AH. Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages. Am J Respir Cell Mol Biol 1993; 9:73-81.
141. Limper AH. Adhesive glycoproteins in the pathogenesis of Pneumocystis carinii pneumonia: host defense or microbial offense? [editorial; comment]. J Lab Clin Med 1995; 125:12-13.
142. Benfield TL, Lundgren B, Shelhamer JH, Lundgren JD. Pneumocystis carinii major surface glycoprotein induces interleukin-8 and monocyte chemoattractant protein-1 release from a human alveolar epithelial cell line. Eur J Clin Invest 1999; 29(8): 717-722.
143. Turner CM, Barry JD. High frequency of antigenic variation in Trypanosoma brucei rhodesiense infections. Parasitology 1989; 99(Pt 1):67-75.
144. Borst P, Fairlamb AH. Surface receptors and transporters of Trypanosoma brucei. Annu Rev Microbiol 1998; 52:745-778.
145. Cavalier-Smith T. What are Fungi? In: McLaughlin D, McLaughlin EG, Lemke PA, Eds. The Mycota:Systematics and Evolution. 1994:3-37.
146. Svard SG, Meng TC, Hetsko ML, McCaffery JM, Gillin FD. Differentiation-associated surface antigen variation in the ancient eukaryote Giardia lamblia. Mol Microbiol 1998; 30:979-989.